Desidustat: Zydus Cadila gets approval from Mexican authorit
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Drug firm Zydus Cadila on Monday (6 July) said it has received approval from Mexico's regulatory authority Cofepris to test one of its lead research candidate Desidustat in the management of COVID-19.

"Clinical and regulatory development of Desidustat in COVID-19 is being executed in Mexico by Avant Santé Research Center S.A. de C.V., a leading contract research organisation headquartered in Monterrey, Mexico," Cadila Healthcare

The company said it will conduct a study to evaluate the efficacy and safety of Desidustat tablets for the management of COVID-19 patients.

"As a part of the study, 100 mg tablets of Desidustat will be administered for a period of 14 days along with recommended standard care during the trial," the company added.

Zydus had initiated two phase-III trials of Desidustat.

Source: https://www.tribuneindia.com/news/nation/indias-zydus-cadila-gets-approval-from-mexico-to-test-covid-19-drug-109312
P●●●●i P●●●●●n and 10 others like this4 shares
Like
Comment
Share
B●●●●●●●●a J●●●●●t S●●●h
B●●●●●●●●a J●●●●●t S●●●h General Medicine
Lets use in open trial and closely observe action in covid +ve cases.
Jul 6, 2020Like
B●●●●●●●●a J●●●●●t S●●●h
B●●●●●●●●a J●●●●●t S●●●h General Medicine
What os its action exact mechanism.
Jul 6, 2020Like